Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2026 07:30 ET | Source: Entact Bio

Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors

A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics.Dr. Houston's deep experience...